Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Joe Rahamim"'
Autor:
Jonathan Unsworth-White, Andrew R L Medford, Pjk Pearson, Y M Awan, Joe Rahamim, Adrian Marchbank
Publikováno v:
University of Bristol-PURE
INTRODUCTION Video-assisted thoracoscopic surgery (VATS) is the gold standard investigation for diagnosis of pleural exudates. It is invasive and it is important to ensure that it is performed to acceptable national standards. We assumed that VATS em
Publikováno v:
Anti-Cancer Drugs. 18:1227-1230
At present, there is no clear consensus on the most appropriate treatment approach for large cell neuroendocrine carcinoma of the lung. Large cell neuroendocrine carcinoma lesions differ from other nonsmall cell lung carcinomas in that they have a pa
Publikováno v:
The Annals of The Royal College of Surgeons of England. 88:358-362
INTRODUCTION Patients with oesophageal carcinoma are at high risk of malnutrition. The aim of this study was to assess current practice for the nutritional management of patients following surgery for oesophageal carcinoma. PATIENTS AND METHODS A pos
Autor:
Joe Rahamim, Jaime Villaquiran, Samer Bazerbashi, Michael Jonathan Unsworth-White, Mark J. Bennett
Publikováno v:
The Annals of Thoracic Surgery. 86:1367-1369
Esophageal perforation is a rare, but life-threatening condition with a mortality rate ranging between 10% and 40%. It can happen at the level of the cervical, intrathoracic, or intra-abdominal segment. It usually occurs as a result of iatrogenic inj
Autor:
Joe Rahamim, Samer Bazerbashi, Adrian Marchbank, Jaime Villaquiran, Michael Jonathan Unsworth-White, Mohammad Yousaf Awan
Publikováno v:
Annals of surgical oncology. 16(12)
Malignant pleural effusions are common and can be difficult to manage. We have reviewed our use of ambulatory drains (Pleurex drains) in this regard with particular reference to hospital stay, duration of drainage, and incidence of complications. Of
Publikováno v:
Journal of Thoracic Oncology. 2:S700
Autor:
Sharon Glaysher, Mark E F Smith, Paul Modi, Louise A. Knight, Mya Gyi, Zoe Goldthorpe, Peter E. Andreotti, Ajit Narayanan, Matthew Poole, Tim J. Gulliford, Dennis Yiannakis, Francis G Gabriel, Ian A. Cree, Katharine Peregrin, Marta E Polak, Khalid Amer, Bruce J. Addis, Joe Rahamim, Penny Johnson
Publikováno v:
BMC Cancer
Glaysher, S, Yiannakis, D, Gabriel, F G, Johnson, P, Polak, M E, Knight, L A, Goldthorpe, Z, Peregrin, K, Gyi, M, Modi, P, Rahamim, J, Smith, M E, Amer, K, Addis, B, Poole, M, Narayanan, A, Gulliford, T J, Andreotti, P E & Cree, I A 2009, ' Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC) ', BMC Cancer, vol. 9, pp. 300 . https://doi.org/10.1186/1471-2407-9-300
BMC Cancer, Vol 9, Iss 1, p 300 (2009)
Glaysher, S, Yiannakis, D, Gabriel, F G, Johnson, P, Polak, M E, Knight, L A, Goldthorpe, Z, Peregrin, K, Gyi, M, Modi, P, Rahamim, J, Smith, M E, Amer, K, Addis, B, Poole, M, Narayanan, A, Gulliford, T J, Andreotti, P E & Cree, I A 2009, ' Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC) ', BMC Cancer, vol. 9, pp. 300 . https://doi.org/10.1186/1471-2407-9-300
BMC Cancer, Vol 9, Iss 1, p 300 (2009)
Background NSCLC exhibits considerable heterogeneity in its sensitivity to chemotherapy and similar heterogeneity is noted in vitro in a variety of model systems. This study has tested the hypothesis that the molecular basis of the observed in vitro